Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Peter Hendrickson
Medical Instructor in the Department of Radiation Oncology
Radiation Oncology
peter.hendrickson@duke.edu
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Professional Training and Employment
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: false}
Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
Defining and targeting CIC::DUX4-dependent survival in fusion-positive sarcomas
Fellowship
Collaborator ·
Awarded by National Institutes of Health ·
2025 - 2028
Evaluation of a selective COP1-ETS family dependency axis in CIC::DUX4+ Ewing-like sarcomas
Research
Co-Principal Investigator ·
Awarded by St. Baldrick's Foundation ·
2025 - 2027
Hyperactivating oncogenic ETS factors to selectively target CIC-rearranged sarcomas
Research
Principal Investigator ·
Awarded by Alex's Lemonade Stand ·
2025 - 2025
Tripping the core regulatory circuitry: Evaluating the tumor-intrinsic and extrinsic effects of Triptolide in CIC-DUX4 sarcoma (CDS)
Research
Principal Investigator ·
Awarded by American Society of Clinical Oncology ·
2024 - 2025
Ewing-like sarcoma: Targeting the CIC-DUX4 oncoprotein through epigenetic inhibitors
Research
PI-Fellow ·
Awarded by American Society for Radiation Oncology ·
2022 - 2024
